<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02016222</url>
  </required_header>
  <id_info>
    <org_study_id>RC-P0006</org_study_id>
    <nct_id>NCT02016222</nct_id>
  </id_info>
  <brief_title>Tear Analysis in the Diagnosis of Multiple Sclerosis</brief_title>
  <acronym>LARMES</acronym>
  <official_title>Tear Analysis in the Diagnosis of Primary Progressive Forms of Multiple Sclerosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Lille Catholic University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Bayer</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Lille Catholic University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In the primary progressive multiple sclerosis, the detection of oligoclonal bands in
      cerebrospinal fluid is critical for the diagnosis. However, lumbar puncture for cerebrospinal
      fluid collection is considered relatively invasive. Our hypothesis is that oligoclonal bands
      detection in tears is possible and useful for the diagnosis of multiple sclerosis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The objective of the present study is to assess concordance between oligoclonal bands
      detection in tears and in cerebrospinal fluid. We will include patients with primary
      progressive multiple sclerosis and we will compare results of oligoclonal bands detection by
      isoelectric focusing in cerebrospinal fluid and tears. Tears will be collected using a
      Schirmer strip. This would circumvent the practice of invasive lumbar punctures currently
      used in multiple sclerosis diagnosis.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2011</start_date>
  <completion_date type="Actual">March 2016</completion_date>
  <primary_completion_date type="Actual">March 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Concordance between the quantification of oligoclonal IgG bands by isoelectric focusing in tears and in the cerebrospinal fluid in patients with primary progressive multiple sclerosis</measure>
    <time_frame>at baseline and two years after (+/- 2 months)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Isoelectrophoretic profile of tears</measure>
    <time_frame>Baseline and two years after inclusion</time_frame>
    <description>Determination of the stability and prognostic value of isoelectrophoretic profile of tears at inclusion, after 2 years.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Isoelectrophoretic profiles of tears by digital recording and analysis of images</measure>
    <time_frame>Baseline and two years after</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">80</enrollment>
  <condition>Primary Progressive Multiple Sclerosis</condition>
  <arm_group>
    <arm_group_label>Tears sampling</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>tears sampling</intervention_name>
    <arm_group_label>Tears sampling</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 years old or more

          -  Progressive neurological deficit after 12 months

          -  At least 9 T2 brain lesions of minimum 3 mm evidenced by MRI and/or four or more T2
             lesions of minimum 3 mm with positive Visual Evoked Potential and/or positive spinal
             cord MRI (at least two focal T2 lesions)

        Exclusion Criteria:

          -  Asiatic persons

          -  recurrent forms of the disease

          -  Persons wearing contact lenses

          -  Ocular Infection

          -  Corticoid treatment at least 30 days before sampling

          -  immunosuppressive or immunomodulatory treatment 3 months before sampling
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Patrick Hautecoeur, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Groupement des Hôpitaux de l'Institut Catholique de Lille (GHICL)</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Elisabeth Baumelou, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Groupement des Hôpitaux de l'Institut Catholique de Lille</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Patrick Vermersch, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Hospitalier Régional, Universitaire de Lille</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Christine Lebrun-Frenay, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Hospitalier Universitaire de Nice</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jérome De Sèze, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Hospitalier Régional Universitaire de Strasbourg</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Thibaut Moreau, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Hospitalier Universitaire de Dijon</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Pierre Clavelou, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Hospitalier Régional Universitaire de Clermont-Ferrand</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Olivier Heinzlef, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre hospitalier intercommunal de Poissy</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Christian Confavreux, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospices Civils de Lyon</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Marc Debouverie, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Central Hospital, Nancy, France</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jean Pelletier, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>L'assistance Publique des Hôpitaux de Marseille</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Bruno Brochet, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Hospitalier Universitaire De Bordeaux</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Gilles Defer, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Hospitalier universitaire de Caen</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Eric Thouvenot, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Hospitalier Universitaire de Nîmes</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centre hospitalier universitaire (CHU), Nice</name>
      <address>
        <city>Nice</city>
        <state>Alpes Maritimes</state>
        <zip>06003</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Groupement des Hôpitaux de l'Institut Catholique de Lille (GHICL)</name>
      <address>
        <city>Lille</city>
        <state>Nord</state>
        <zip>59000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre hospitaliere universitaire</name>
      <address>
        <city>Bordeaux</city>
        <zip>33404</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre hospitalier universitaire</name>
      <address>
        <city>Caen</city>
        <zip>14033</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre hospitalier régional universitaire</name>
      <address>
        <city>Clermont-Ferrand</city>
        <zip>63003</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre hospitalier universitaire</name>
      <address>
        <city>Dijon</city>
        <zip>21079</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre hospitalier régional universitaire</name>
      <address>
        <city>Lille</city>
        <zip>59037</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospices civils de Lyon</name>
      <address>
        <city>Lyon</city>
        <zip>69229</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Assistance Publique - Hôpitaux de Marseille</name>
      <address>
        <city>Marseille</city>
        <zip>13354</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre hospitalier universitaire</name>
      <address>
        <city>Nancy</city>
        <zip>54035</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre hospitalier universitaire</name>
      <address>
        <city>Nimes</city>
        <zip>30029</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre hospitalier intercommunal</name>
      <address>
        <city>Poissy</city>
        <zip>78303</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre hospitalier régional universtaire</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 22, 2013</study_first_submitted>
  <study_first_submitted_qc>December 18, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 19, 2013</study_first_posted>
  <last_update_submitted>September 19, 2016</last_update_submitted>
  <last_update_submitted_qc>September 19, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 20, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>primary progressive multiple sclerosis</keyword>
  <keyword>diagnosis</keyword>
  <keyword>tears</keyword>
  <keyword>isoelectric focusing</keyword>
  <keyword>oligoclonal bands</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sclerosis</mesh_term>
    <mesh_term>Multiple Sclerosis</mesh_term>
    <mesh_term>Multiple Sclerosis, Chronic Progressive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

